3320 — China Resources Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$28.93bn
- HK$167.93bn
- CNY269.57bn
Brief: China Resources Pharmaceutical Posts FY Net Profit Attributable RMB444.7 Mln For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Posts FY Total Operating Revenue For CR Boya Bio-Pharmaceutical
Brief: China Resources Pharmaceutical Announces Proposed Internal Reorganization Involving CR Zizhu
Brief: China Resources Pharmaceutical Announces Entrusted Construction Deal
Brief: China Resources Pharmaceutical Says FY Total Operating Revenue Of Jiangzhong Pharmaceutical Increased By 13%
Brief: China Resources Pharmaceutical Says Proposed Increase Of Registered Capital By CR Pharma Commercial
Brief: China Resources Pharmaceutical Says Deng Rong Appointed As Executive Director
Brief: China Resources Pharmaceutical Announces Proposed Acquisition Of Additional Stake In CR Jiangzhong
Brief: China Resources Pharmaceutical Updates On Potential Issuance Of Shares By CR Pharmaceutical Commercial
Brief: China Resources Pharmaceutical Says Potential Issuance Of Shares By CR Pharmaceutical Commercial
Brief: China Resources Pharmaceutical Says 9-Month Revenue For KPC Pharmaceuticals RMB5.61 Bln
Brief: China Resources Pharmaceutical Says 9-Mth China Resources Boya Bio-Pharmaceutical Rev RMB2.19 Bln
Brief: China Resources Pharmaceutical Posts HY Profit Attributable HK$3.04 Bln
Brief: China Resources Pharmaceutical Says HY Revenue For KPC Pharmaceuticals RMB3.77 Bln
Brief: China Resources Pharmaceutical Says Deng Rong Has Been Appointed As Chief Financial Officer
Brief: China Resources Pharmaceutical Says Registration,Completion Of Issuance Of 2023 First Tranche Bonds
China Resources Pharmaceutical hits over 3-year high on unit's strong Q1
Brief: China Resources Pharmaceutical Posts Qtrly Jiangzhong Pharmaceutical Net Profit RMB258.0 Million
Brief: China Resources Pharmaceutical Group Posts Qtrly Results For Jiangzhong Pharmaceutical